Concepedia

Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study

Namiki Izumi, Yasuhiro Asahina, Masayuki Kurosaki, Gotaro Yamada, Tsutomu Kawai, Eiji Kajiwara, Yukishige Okamura, Takayuki Takeuchi, Osamu Yokosuka, Kazuya Kariyama,

Journal of Gastroenterology · 2012 · 21 citations · 34 references

DOIFull text

Open access

Abstract

Low-dose and long-term maintenance administration of PegIFNα-2a decreased the incidence of HCC in patients with normalized ALT and AFP levels at 24 weeks compared with patients without normal ALT and AFP levels.

References

34

Global cancer statistics

Ahmedin Jemal, Freddie Bray · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text

Global Cancer Statistics, 2002

Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2005 · 18.4K citations · Full text

, , +16

Hepatocellular carcinoma

Josep M. Llovet, Andrew K. Burroughs, Jordi Bruix · The Lancet · 2003 · 3.6K citations

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Dongliang Ge, Jacques Fellay, Alexander Thompson et al. · Nature · 2009 · 3.5K citations · Full text

, , +9

Classification of chronic hepatitis: Diagnosis, grading and staging

Valeer Desmet, Michael A. Gerber, Jay H. Hoofnagle et al. · Hepatology · 1994 · 2.6K citations

, , +7